MERCK Kommanditgesellschaft auf Aktien

MERCK Kommanditgesellschaft auf Aktien, headquartered in Germany and operating in Pharmaceutical Preparation Manufacturing, reported total carbon emissions of approximately 4.75 billion kg CO2e in 2025. This includes Scope 1 emissions of 658 million kg CO2e, Scope 2 emissions (market-based) of 197.07 million kg CO2e, and Scope 3 emissions of 3.896 billion kg CO2e. Key categories within Scope 3 include purchased goods and services (2.048 billion kg CO2e), use of sold products (927.96 million kg CO2e), and capital goods (293.56 million kg CO2e).

Looking back, the company's total emissions were approximately 5.57 billion kg CO2e in 2024, comprising Scope 1 emissions of 858.05 million kg CO2e, Scope 2 market-based emissions of 227.07 million kg CO2e, and Scope 3 emissions of 4.483 billion kg CO2e. In 2020, the company reported total emissions of approximately 7.256 billion kg CO2e, with Scope 1 at 1.827 billion kg CO2e, Scope 2 market-based at 324.7 million kg CO2e, and Scope 3 at 5.105 billion kg CO2e.

MERCK Kommanditgesellschaft auf Aktien has set ambitious climate commitments. It aims to reduce absolute Scope 1 and Scope 2 greenhouse gas emissions by 50% by 2030, using 2020 as the baseline year. Additionally, the company commits to reducing Scope 3 greenhouse gas emissions by 52% per euro value added by 2030, also against a 2020 baseline. These near-term targets for Scope 1, 2, and 3 have been approved by the Science Based Targets initiative (SBTi) and are classified as consistent with reductions required to keep warming to 1.5°C. The company also has a long-term goal to achieve climate neutrality across its entire value chain (covering Scope 1, 2, and 3 emissions) by 2040.

Emissions and climate commitment data for MERCK Kommanditgesellschaft auf Aktien are inherited from its parent company, Merck KGaA.